IRADIMED CORPORATION
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $23.1M | $32.5M | $31.6M | $15.7M | $11.3M |
| Cost of Revenue | $5.6M | $6.2M | $5.8M | $3.4M | $2.9M |
| Gross Profit | $17.5M | $26.3M | $25.8M | $12.2M | $8.5M |
| Gross Margin | 75.9% | 81.1% | 81.5% | 78.3% | 74.8% |
| Operating Expenses | |||||
| Research & Development | $1.7M | $1.3M | $1.8M | $1.1M | $1.0M |
| SG&A Expense | $9.0M | $8.8M | $7.8M | $4.8M | $2.4M |
| Operating Income | $1.3M | $10.9M | $11.5M | $3.1M | $2.8M |
| Operating Margin | 5.6% | 33.6% | 36.4% | 19.6% | 24.6% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $1.4M | $11.0M | $11.6M | $3.0M | $2.8M |
| Income Tax Expense | $896.6K | $3.7M | $4.1M | $967.0K | $846.9K |
| Net Income | $499.8K | $7.2M | $7.5M | $2.1M | $1.9M |
| Net Margin | 2.2% | 22.2% | 23.8% | 13.1% | 17.1% |
| EPS (Basic) | $0.05 | $0.67 | $0.68 | $0.23 | $0.28 |
| EPS (Diluted) | $0.04 | $0.60 | $0.60 | $0.20 | $0.22 |
| Shares Outstanding (Basic) | 10.6M | 10.8M | 11.0M | 8.7M | 7.0M |
| Shares Outstanding (Diluted) | 11.7M | 12.0M | 12.6M | 10.2M | 8.6M |
| Dividends Per Share | — | — | — | — | — |